IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Istanbul Veterinary Sciences
  • Vetexpo-2022 Special Issue
  • A case of cutaneous mast cell tumor in a dog

A case of cutaneous mast cell tumor in a dog

Authors : Bengü BİLGİÇ, Hazal ÖZTÜRK GÜRGEN, Can ÖZTÜRK, Banu DOKUZEYLÜL, Mehmet Erman OR
Pages : 206-206
View : 16 | Download : 6
Publication Date : 2023-01-05
Article Type : Other Papers
Abstract :Cutaneous mast cell tumors comprise approximately 20% of cutaneous tumors in dogs. It is commonly seen as solitary nodules on the skin. A 14-year-old, male, labrador crossbreed dog was brought to the Istanbul University-Cerrahpaşa Veterinary Faculty internal medicine policlinic due to the formation of generalized nodules that started on the right hind leg and spread to the head, abdomen, scrotum and lateral thorax within a month. On physical examination, body temperature was 39,1°C, swelling in the submandibular lymph nodes, and widespread erythematous and nodular structures on the skin were observed. Hemogram and serum biochemistry analyzes were within normal ranges. Biopsies were taken from 0,5 – 0,6 cm diameter nodules in order to reach a definitive diagnosis of the patient who had not received any treatment before. Neoplastic mast cell accumulations with rounded morphology were observed in the dermis. Masitinib 12,5 mg/kg/day, PO insert ignore into journalissuearticles values(Masivet®); was administered to the patient who was diagnosed with Stage 2 cutaneous mast cell tumor according to Patnaik grading system. After 17 days of treatment, the patient showed significant clinical improvement. The disease relapsed after a 1-month break from the treatment. 15 mg/kg/day PO, Mastinib together with 1 mg/kg methylprednisolone insert ignore into journalissuearticles values(Prednol®); 1mg/kg PO were administered, but no regression was observed in the nodules. Due to severe lethargy, vomiting, anorexia, and spread of the masses, the patient was euthanized with the request of the owner. In our opinion, cutaneous mast cell tumors should be considered by clinician veterinarians in the evaluation of nodular skin diseases.
Keywords : Mast cell, tumour, dog, masitinib

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025